Rangeley Capital, LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$120.4M

Holdings

117

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (117 positions)

#StockSharesValue% PortfolioType
101
RAAQREAL ASSET ACQUISITION CORP
10,000$102K0.08%
102
PMTRPERIMETER ACQUISITION CORP I
10,000$102K0.08%
103
MCGAYORKVILLE ACQUISITION CORP.
10,000$102K0.08%
104
SITCSITE CTRS CORP
14,000$89K0.07%
105
75ZSOHO HOUSE & CO INC
10,000$89K0.07%
106
ANTXAN2 THERAPEUTICS INC
65,000$74K0.06%
107
BRNSBARINTHUS BIOTHERAPEUTICS PL
84,441$59K0.05%
108
NKTXNKARTA INC
32,078$59K0.05%
109
VYNEVYNE THERAPEUTICS INC
100,000$58K0.05%
110
PMVPPMV PHARMACEUTICALS INC
45,500$56K0.05%
111
ANEBANEBULO PHARMACEUTICALS INC
50,000$50K0.04%
112
MGNXMACROGENICS INC
30,220$48K0.04%
113
SEERSEER INC
20,000$36K0.03%
114
ALTSALT5 SIGMA CORP
29,000$31K0.03%
115
RLYBRALLYBIO CORP
40,000$27K0.02%
116
EMISEMMIS ACQUISITION CORP.
18,107$18K0.01%
117
MLACMOUNTAIN LAKE ACQUISITION CO
15,000$15K0.01%
PreviousPage 2 of 2